PedAM
Pediatric Disease Annotations & Medicines
| Disease | hepatitis |
| Phenotype | C0022658|kidney disease |
| Sentences | 18 |
| PubMedID- 23823603 | hepatitis c treatment in patients with kidney disease. |
| PubMedID- 25904153 | A meta-analytic assessment of the risk of chronic kidney disease in patients with chronic hepatitis c virus infection. |
| PubMedID- 21745269 | The most frequent kidney disease associated with chronic hepatitis c virus (hcv) infection is membranoproliferative glomerulonephritis in patients with type ii mixed cryoglobulinaemia. |
| PubMedID- 25362901 | Interferon-based therapy remains the gold standard for hepatitis c in patients with chronic kidney disease; however, due to the high rate of ifn-induced rejection after transplant, treatment of hcv-infected kidney transplant recipients is recommended only in particular circumstances. |
| PubMedID- 25593456 | Management of hepatitis c in patients with chronic kidney disease. |
| PubMedID- 24299322 | Background: the treatment of chronic hepatitis b (chb) in patients with chronic kidney disease (ckd) is based on nucleoside (lamivudine, telbivudine, entecavir) or nucleotide (adefovir, tenofovir) analogues (nas), but it may be complex and the information is scarce. |
| PubMedID- 22930501 | Unexpected distribution of hepatitis b genotypes in patients with kidney disease: comparison with immunocompetent subjects. |
| PubMedID- 25018934 | Recently published kdigo guidelines for treatment of viral hepatitis in patients with kidney disease suggest that patients with moderate proteinuria and slowly progressive kidney disease can be treated with a 12-month course of standard interferon-α or pegylated interferon-α-2a with dose adjusted as described below plus ribavirin, with or without erythropoietin support, depending on the level of hemoglobin.342 ribavirin dose needs to be titrated according to patient tolerance; caution is advised for patients with clearance <50 ml/min which may require substantially reduced dosage. |
| PubMedID- 23783238 | Treatment of hepatitis b in patients with chronic kidney disease. |
| PubMedID- 20081297 | Nevertheless, there are several questions about the indications of kidney transplantation, pretransplant evaluation, transplantation from hcv-infected donors, patient and graft survival rates, and kidney diseases associated with hepatitis c virus after kidney transplantation. |
| PubMedID- 21883737 | Development rate of chronic kidney disease in hepatitis c virus patients with advanced fibrosis after interferon therapy. |
| PubMedID- 26481484 | A review of direct-acting antivirals for the treatment of hepatitis c in patients with advanced chronic kidney disease. |
| PubMedID- 22142584 | Vitamin d deficiency is associated with poor response to active hepatitis b immunisation in patients with chronic kidney disease. |
| PubMedID- 22161023 | Management of hepatitis c in patients with chronic kidney disease. |
| PubMedID- 24984337 | The paper presents guidelines for serologic and molecular diagnosis of hepatitis c in patients with chronic kidney disease, recommendations for the treatment of hcv infection in these patients and the prevention of transmission of hcv in hemodialysis units. |
| PubMedID- 22224074 | Immune response to hepatitis b vaccine in patients with chronic kidney disease. |
| PubMedID- 24592546 | The advent of nucleos(t)ide analogues offers the opportunity to change the natural history of hepatitis b in patients with chronic kidney disease. |
| PubMedID- 21755059 | The prevalence of hepatitis c in patients with chronic kidney disease (ckd) on hemodialysis (hd) is higher than that in the general population. |
Page: 1